Abstract PS3-07-23: Survivor plots for quantitated adjunctive statistically standardized ER, PgR, and HER2 in adjuvant postmenopausal breast cancer: Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: J. W. Chapman, J. Bayani, S. SenGupta, J. M. S. Bartlett, T. Piper, M. A. Quintayo, S. Virk, P. E. Goss, J. N. Ingle, M. J. Ellis, G. W. Sledge, G. T. Budd, M. Rabaglio, R. H. Ansari, R. Tozer, D. P. D'Souza, H. Chalchal, S. Spadafora, V. Stearns, E. A. Perez, K. A. Gelmon, T. J. Whelan, C. Elliott, L. E. Shepherd, B. E. Chen, K. J. Taylor
Institutions: Queen's University, University of Toronto, University of Edinburgh, Harvard University, Mayo Clinic, Caris Life Sciences (United States), Cleveland Clinic, University Hospital of Bern, Indiana University South Bend, McMaster University, London Health Sciences Centre, Weill Cornell Medicine, University of British Columbia
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130689305
Cites:
Cited by:
Related to:
